Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Aug-24 8:05 PM View:  | Schaefer Thomas J. Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Aug-24 | Purchase | 700 | $2.06 | $1,442.00 | 49% 1.42K to 2.12K | |
| 20-Aug-24 8:11 PM View: | Kawakami Mark Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Aug-24 | Purchase | 700 | $2.06 | $1,442.00 | 55% 1.28K to 1.98K | |
| 05-Feb-24 4:29 PM View: | Schaefer Thomas J. Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Feb-24 | Purchase | 700 | $2.06 | $1,442.00 | 97% 0.72K to 1.42K | |
| 07-Aug-23 7:55 PM View: | Schaefer Thomas J. Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 04-Aug-23 | Purchase | 649 | $3.67 | $2,381.83 | 927% 70 to 0.72K | |
| 30-May-23 6:24 PM View: | Jacot Stanley Jr Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 30-May-23 | Purchase | 5,000 | $4.31 | $21,550.00 | 100% 0 to 5.0K | |
| 02-Feb-23 7:07 PM View: | Schaefer Thomas J. Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Feb-23 | Private Purchase | 700 | $0.23 | $161.00 | 33% 2.1K to 2.8K | |
| 03-Aug-22 5:23 PM View: | Haley Pamela Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Aug-22 | Private Purchase | 700 | $0.70 | $490.00 | 16% 4.39K to 5.09K | |
| 25-Jan-21 6:43 PM View: | Haley Pamela Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Aug-20 | Private Purchase | 700 | $3.16 | $2,212.00 | 36% 1.94K to 2.64K | |
| 25-Jan-21 6:51 PM View: | Plavan Matthew T Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Aug-20 | Private Purchase | 585 | $3.16 | $1,848.60 | 4% 13.7K to 14.29K | |
| 25-Jan-21 6:47 PM View: | Shultz Randall Chief Technology Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Aug-20 | Private Purchase | 700 | $3.16 | $2,212.00 | 6% 12.3K to 13.0K | |
| 04-Feb-20 4:13 PM View: | Reiter Sarah Chief Commercial Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Feb-20 | Private Purchase | 700 | $1.72 | $1,204.00 | 23% 3.1K to 3.8K | |
| 04-Feb-20 4:14 PM View: | Haley Pamela Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Feb-20 | Private Purchase | 700 | $1.72 | $1,204.00 | 57% 1.24K to 1.94K | |
| 04-Feb-20 4:11 PM View: | Plavan Matthew T Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 03-Feb-20 | Private Purchase | 700 | $1.72 | $1,204.00 | 5% 13.0K to 13.7K | |
| 23-Dec-19 4:50 PM View: | Reiter Sarah Chief Commercial Officer | Arcadia Biosciences, Inc. (RKDA) | 23-Dec-19 | Market Purchase | 900 | $5.95 | $5,355.00 | 41% 2.2K to 3.1K | (52%) |
| 20-Nov-19 9:00 AM View: | Reiter Sarah Chief Commercial Officer | Arcadia Biosciences, Inc. (RKDA) | 19-Nov-19 | Market Purchase | 1,000 | $4.52 | $4,520.00 | 83% 1.2K to 2.2K | (37%) |
| 19-Nov-19 10:50 AM View: | Murray Lilian Shackelford Director | Arcadia Biosciences, Inc. (RKDA) | 18-Nov-19 | Market Purchase | 5,000 | $4.25 | $21,250.00 | 142% 3.52K to 8.52K | (33%) |
| 18-Nov-19 1:32 PM View: | Plavan Matthew T Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 14-Nov-19 | Market Purchase | 1,000 | $4.08 | $4,079.50 | 8% 12.0K to 13.0K | (31%) |
| 23-Sep-19 7:18 PM View: | Plavan Matthew T Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 23-Sep-19 | Market Purchase | 2,000 | $5.25 | $10,500.00 | 20% 10.0K to 12.0K | (46%) |
| 17-Sep-19 7:54 PM View: | Comcowich Kevin Director | Arcadia Biosciences, Inc. (RKDA) | 17-Sep-19 | Market Purchase | 5,000 | $5.88 | $29,388.00 | 33% 15.0K to 20.0K | (52%) |
| 10-Sep-19 5:57 PM View: | Comcowich Kevin Director | Arcadia Biosciences, Inc. (RKDA) | 10-Sep-19 | Market Purchase | 15,000 | $6.49 | $97,333.00 | 100% 0 to 15.0K | (56%) |
| 10-Sep-19 6:02 PM View: | Reiter Sarah Chief Commercial Officer | Arcadia Biosciences, Inc. (RKDA) | 10-Sep-19 | Market Purchase | 1,200 | $6.48 | $7,776.00 | 100% 0 to 1.2K | (56%) |
| 10-Sep-19 6:24 PM View: | Plavan Matthew T Chief Executive Officer | Arcadia Biosciences, Inc. (RKDA) | 10-Sep-19 | Market Purchase | 2,000 | $6.51 | $13,013.50 | 25% 8.0K to 10.0K | (57%) |
| 28-Aug-19 10:31 AM View: | Plavan Matthew T Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 28-Aug-19 | Grant | 1,000 | $6.88 | $6,880.00 | 14% 7.0K to 8.0K | (59%) |
| 28-Aug-19 10:31 AM View: | Plavan Matthew T Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 27-Aug-19 | Grant | 5,000 | $9.09 | $45,430.00 | 250% 2.0K to 7.0K | (69%) |
| 28-Aug-19 10:31 AM View: | Plavan Matthew T Chief Financial Officer | Arcadia Biosciences, Inc. (RKDA) | 26-Aug-19 | Grant | 2,000 | $8.77 | $17,550.00 | 100% 0 to 2.0K | (68%) |
| 27-Mar-18 5:40 PM View: | Lu Zhongjin VP Product Development | Arcadia Biosciences, Inc. (RKDA) | 23-Mar-18 | Market Option Sale | 1,750 | $32.74 | $57,295.00 | (76%) 2.31K to 0.56K | 91% |
| 27-Mar-18 5:42 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 23-Mar-18 | Option Exercise | 5,000 | $21.60 | $108,000.00 | 68% 7.33K to 12.34K | |
| 27-Mar-18 5:42 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 23-Mar-18 | Market Option Sale | 5,000 | $33.44 | $167,200.00 | (41%) 12.34K to 7.33K | 92% |
| 27-Mar-18 5:40 PM View: | Lu Zhongjin VP Product Development | Arcadia Biosciences, Inc. (RKDA) | 23-Mar-18 | Option Exercise | 1,750 | $21.60 | $37,800.00 | 314% 0.56K to 2.31K | |
| 16-Mar-18 8:11 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 15-Mar-18 | Option Exercise | 250 | $44.80 | $11,200.00 | 3% 7.33K to 7.58K | (94%) |
| 16-Mar-18 8:11 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 15-Mar-18 | Market Option Sale (Planned) | 250 | $60.00 | $15,000.00 | (3%) 7.58K to 7.33K | 95% |
| 16-Mar-18 8:11 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 14-Mar-18 | Market Option Sale (Planned) | 21,005 | $45.21 | $949,615.00 | (74%) 28.34K to 7.33K | 94% |
| 16-Mar-18 8:11 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 14-Mar-18 | Option Exercise | 21,005 | $21.60 | $453,708.00 | 286% 7.33K to 28.34K | (87%) |
| 21-Nov-17 12:12 PM View: | Lu Zhongjin VP Product Development | Arcadia Biosciences, Inc. (RKDA) | 17-Nov-17 | Market Sale | 5,950 | $0.23 | $1,356.60 | (35%) 17.1K to 11.15K | 33% |
| 12-Jun-17 1:01 PM View: | Rey Eric J. Director | Arcadia Biosciences, Inc. (RKDA) | 08-Jun-17 | Market Purchase | 5,000 | $0.75 | $3,750.00 | 4% 141.68K to 146.68K | (79%) |
| 08-Aug-16 5:04 PM View: | Salameh Roger Chief Operating Officer | Arcadia Biosciences, Inc. (RKDA) | 04-Aug-16 | Option Exercise | 100 | $1.08 | $108.00 | < 1% 12.71K to 12.81K | |
| 08-Aug-16 5:04 PM View: | Salameh Roger Chief Operating Officer | Arcadia Biosciences, Inc. (RKDA) | 04-Aug-16 | Market Option Sale (Planned) | 100 | $2.51 | $251.00 | (< 1%) 12.81K to 12.71K | 93% |
| 15-Jun-16 4:40 PM View: | Brandwein Steven F. Interim Chief Financ. Officer | Arcadia Biosciences, Inc. (RKDA) | 13-Jun-16 | Market Sale (Planned) | 8,280 | $2.49 | $20,645.40 | (17%) 48.99K to 40.72K | 93% |
| 27-Apr-16 7:35 PM View: | Brandwein Steven F. Interim Chief Financ. Officer | Arcadia Biosciences, Inc. (RKDA) | 25-Apr-16 | Market Sale (Planned) | 1,720 | $2.42 | $4,169.28 | (3%) 50.72K to 48.99K | 93% |
| 06-Apr-16 5:53 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 05-Apr-16 | Market Option Sale (Planned) | 1,653 | $2.98 | $4,929.25 | (3%) 48.79K to 47.13K | 94% |
| 06-Apr-16 5:53 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 05-Apr-16 | Option Exercise | 1,653 | $1.08 | $1,785.24 | 4% 47.13K to 48.79K | |
| 06-Apr-16 5:53 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 04-Apr-16 | Option Exercise | 1,200 | $1.08 | $1,296.00 | 3% 47.13K to 48.33K | |
| 06-Apr-16 5:53 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 04-Apr-16 | Market Option Sale (Planned) | 1,200 | $2.97 | $3,570.00 | (2%) 48.33K to 47.13K | 94% |
| 07-Mar-16 9:24 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 04-Mar-16 | Market Option Sale (Planned) | 2,973 | $3.22 | $9,584.95 | (6%) 50.11K to 47.13K | 95% |
| 07-Mar-16 9:24 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 04-Mar-16 | Option Exercise | 2,973 | $1.08 | $3,210.84 | 6% 47.13K to 50.11K | |
| 07-Mar-16 9:24 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 03-Mar-16 | Market Option Sale (Planned) | 300 | $2.97 | $891.00 | (< 1%) 47.43K to 47.13K | 94% |
| 07-Mar-16 9:24 PM View: | Knauf Vic C. Chief Scientific Officer Director | Arcadia Biosciences, Inc. (RKDA) | 03-Mar-16 | Option Exercise | 300 | $1.08 | $324.00 | < 1% 47.13K to 47.43K | |
| 03-Feb-16 6:33 PM View: | Rey Eric J. President and CEO Director | Arcadia Biosciences, Inc. (RKDA) | 03-Feb-16 | Market Sale (Planned) | 200 | $2.78 | $556.00 | (< 1%) 140.38K to 140.18K | 94% |
| 03-Feb-16 6:35 PM View: | Knauf Vic C. Chief Scientific Officer | Arcadia Biosciences, Inc. (RKDA) | 01-Feb-16 | Market Option Sale (Planned) | 1,666 | $3.00 | $5,003.00 | (3%) 48.8K to 47.13K | 94% |
| 03-Feb-16 6:33 PM View: | Rey Eric J. President and CEO Director | Arcadia Biosciences, Inc. (RKDA) | 01-Feb-16 | Market Sale (Planned) | 3,000 | $2.93 | $8,793.90 | (2%) 143.38K to 140.38K | 94% |
